These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 25841530)

  • 1. Adaptive clinical trial designs in oncology.
    Zang Y; Lee JJ
    Chin Clin Oncol; 2014 Dec; 3(4):49. PubMed ID: 25841530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adaptive clinical trial designs in oncology.
    Zang Y; Lee JJ
    Chin Clin Oncol; 2014 Dec; 3(4):. PubMed ID: 25811018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adaptive designs for confirmatory clinical trials.
    Bretz F; Koenig F; Brannath W; Glimm E; Posch M
    Stat Med; 2009 Apr; 28(8):1181-217. PubMed ID: 19206095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paradigms for adaptive statistical information designs: practical experiences and strategies.
    Wang SJ; Hung HM; O'Neill R
    Stat Med; 2012 Nov; 31(25):3011-23. PubMed ID: 22927234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adaptive designs at European Organisation for Research and Treatment of Cancer (EORTC) with a focus on adaptive sample size re-estimation based on interim-effect size.
    Mauer M; Collette L; Bogaerts J;
    Eur J Cancer; 2012 Jun; 48(9):1386-91. PubMed ID: 22281098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential of adaptive clinical trial designs in pharmacogenetic research.
    van der Baan FH; Knol MJ; Klungel OH; Egberts AC; Grobbee DE; Roes KC
    Pharmacogenomics; 2012 Apr; 13(5):571-8. PubMed ID: 22462749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adaptive designs in clinical trials: why use them, and how to run and report them.
    Pallmann P; Bedding AW; Choodari-Oskooei B; Dimairo M; Flight L; Hampson LV; Holmes J; Mander AP; Odondi L; Sydes MR; Villar SS; Wason JMS; Weir CJ; Wheeler GM; Yap C; Jaki T
    BMC Med; 2018 Feb; 16(1):29. PubMed ID: 29490655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Statistical Designs for Phase I/II and Phase II Clinical Trials With Dose-Finding Objectives.
    Sverdlov O; Wong WK
    Ther Innov Regul Sci; 2014 Sep; 48(5):601-612. PubMed ID: 30231452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seamless phase II/III designs.
    Stallard N; Todd S
    Stat Methods Med Res; 2011 Dec; 20(6):623-34. PubMed ID: 20724313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adaptive clinical trial design.
    Chow SC
    Annu Rev Med; 2014; 65():405-15. PubMed ID: 24422576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical concepts in adaptive clinical trials.
    Park JJ; Thorlund K; Mills EJ
    Clin Epidemiol; 2018; 10():343-351. PubMed ID: 29606891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adaptive designs in clinical drug development--an Executive Summary of the PhRMA Working Group.
    Gallo P; Chuang-Stein C; Dragalin V; Gaydos B; Krams M; Pinheiro J;
    J Biopharm Stat; 2006 May; 16(3):275-83; discussion 285-91, 293-8, 311-2. PubMed ID: 16724485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adaptive design clinical trials: a review of the literature and ClinicalTrials.gov.
    Bothwell LE; Avorn J; Khan NF; Kesselheim AS
    BMJ Open; 2018 Feb; 8(2):e018320. PubMed ID: 29440155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adaptive methods: when and how should they be used in clinical trials?
    Porcher R; Lecocq B; Vray M;
    Therapie; 2011; 66(4):319-26, 309-17. PubMed ID: 21851793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adaptive design implementation in confirmatory trials: methods, practical considerations and case studies.
    Li Q; Lin J; Lin Y
    Contemp Clin Trials; 2020 Nov; 98():106096. PubMed ID: 32739496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulatory perspectives on multiplicity in adaptive design clinical trials throughout a drug development program.
    Wang SJ; Hung HM; O'Neill R
    J Biopharm Stat; 2011 Jul; 21(4):846-59. PubMed ID: 21516573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Group sequential and adaptive designs: a novel, promising tool for nursing research.
    Baldi I; Gouchon SM; Di Giulio P; Buja A; Gregori D
    J Adv Nurs; 2011 Aug; 67(8):1824-33. PubMed ID: 21517937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New clinical trial designs in the era of precision medicine: An overview of definitions, strengths, weaknesses, and current use in oncology.
    Janiaud P; Serghiou S; Ioannidis JPA
    Cancer Treat Rev; 2019 Feb; 73():20-30. PubMed ID: 30572165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adaptive methods: telling "the rest of the story".
    Emerson SS; Fleming TR
    J Biopharm Stat; 2010 Nov; 20(6):1150-65. PubMed ID: 21058111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Practical guidelines for adaptive seamless phase II/III clinical trials that use Bayesian methods.
    Kimani PK; Glimm E; Maurer W; Hutton JL; Stallard N
    Stat Med; 2012 Aug; 31(19):2068-85. PubMed ID: 22437262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.